Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah A Thurman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Medicine & Research|June 3, 2005
Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature reviewJames S Welsh, Sarah A Thurman, Steven P Howard
JAAD Case Reports|June 18, 2025
A case of hereditary <i>CDKN2A</i> p14ARF melanoma and dysplastic neviJeremy K Bray, Sarah A Thurman, Douglas Riegert-Johnson, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Sm-153 EDTMP for recurrent metastatic osteosarcomaJames S Welsh, Sarah A Thurman, Scott Borzillary, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinomaSarah A Thurman, Stuart J Schnitt, James L Connolly, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Medicine & Research|June 3, 2005
Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature reviewJames S Welsh, Sarah A Thurman, Steven P Howard
JAAD Case Reports|June 18, 2025
A case of hereditary <i>CDKN2A</i> p14ARF melanoma and dysplastic neviJeremy K Bray, Sarah A Thurman, Douglas Riegert-Johnson, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Sm-153 EDTMP for recurrent metastatic osteosarcomaJames S Welsh, Sarah A Thurman, Scott Borzillary, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinomaSarah A Thurman, Stuart J Schnitt, James L Connolly, et al.
Pageof 1